SHREE GANESH REMEDIES LTD Financial Ratios
SGRL · Healthcare · Current price ₹709.9
P/E ratio
39.4x
P/B ratio
4.1x
ROE
10.8%
ROCE
19.0%
Debt / Equity
0.19
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 39.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 4.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 10.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 19.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.19 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with SHREE GANESH REMEDIES LTD's latest numbers.
SHREE GANESH REMEDIES LTD profitability
SHREE GANESH REMEDIES LTD generates a return on equity of 10.8% and a return on capital employed of 19.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.19 and a P/E of 39.4x, SHREE GANESH REMEDIES LTD is conservatively financed. Our overall business-quality score for the company is 4.5 / 10.
Understand the ratios
More on SHREE GANESH REMEDIES LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.